MSFT monthly look back and potential move up

MSFT on watch with new variant but with new reports and news of the new variant being not as deadly as DELTA only helps the future of OMICRON diagnosis. It looks/feels like the "flu comparison" of COVID variants. Hopefully we get a tech rally.